IDEXX Laboratories Announces the Addition of the IDEXX I-Vision DR System to its Digital Imaging Offerings [Trade]

Providing long-term value for practices so they can provide the best care and service for patients and clients

WESTBROOK, Maine, March 11, 2013—IDEXX Laboratories, Inc. announces the North America launch of a new direct-capture solution in its line of IDEXX I-Vision Digital Imaging Systems. The family now includes three system offerings: the new IDEXX I-Vision DR System and the IDEXX I-Vision CR System (both powered by IDEXX-PACS Imaging Software) and the IDEXX I-Vision CR System with Capture Imaging Software. With this launch, IDEXX radiography offers options to fit the needs of practices of all sizes, providing the efficiency, speed and image quality that lets them better serve their patients and clients.

“IDEXX Digital Imaging continues to focus on innovations that not only give staff more quality time with patients and clients, but also ensure that our systems evolve with individual practice requirements,” says Penny Guyton, Senior Director and General Manager of IDEXX Digital Imaging. “With the range of digital imaging choices in the market, it’s important for veterinary practices to consider what happens after their system is out of the box. Are there ongoing software and system upgrades? In addition to helping configure the system to fit specific practice needs, installing it and training the staff, IDEXX will be there for the long haul with unmatched customer service, support, education and software enhancements such as the Image Coach tools in IDEXX-PACS 3.6 that guide technicians in optimizing image quality in real time.”

The latest addition to the IDEXX radiography product line, the IDEXX I-Vision DR System captures images in seconds. Its slim profile allows for easy retrofits to existing exam rooms and faster installations. This system is powered by IDEXX-PACS, which features industry-leading diagnostic software tools for viewing and enhancing images so practitioners have the highest level of diagnostic confidence.

“With digital imaging, we’re more apt to take the images we need,” says James Moebius, DVM, of Murphy Road Animal Hospital in Sachse, Texas. “When you’re using film, especially when it’s not an easy patient to handle, there’s a part of you that says it’s not worth the hassle. When you know you’re going to get a good image the first time, you’re more likely to order it. If you’re taking more images, it improves patient care as well as your bottom line. You’re making better decisions, and that’s good for everyone.”

The IDEXX I-Vision DR System is available now. To learn more about IDEXX digital imaging systems, call 1-855-627-6573 or visit idexx.com/ivisiondr (U.S.) or idexx.ca/ivisiondr (Canada).

About IDEXX Digital Imaging
IDEXX Digital Imaging offers an innovative line of digital radiography systems that provide the highest standard of image sharpness and clarity in just one exposure. Practitioners can view images within seconds and, using IDEXX-PACS veterinary-specific image management software, can easily store images in electronic patient medical records for immediate access and sharing with radiology consultants.

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the livestock and poultry industries as well as tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs approximately 5,400 people and offers products to customers in over 175 countries.

Note Regarding Forward-looking Statements
This press release contains statements about the Company's business prospects for future periods that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as "expects," "may," "anticipates," "intends," "would," "will," "plans," "believes," "estimates," "should," and similar words and expressions. These statements are based on management's expectations of future events as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Actual results could differ materially from management's expectations. Factors that could cause or contribute to such differences include the following: the Company's ability to develop, manufacture, introduce and market new products and enhancements to existing products; the Company's ability to develop, manufacture, introduce and market new products and enhancements to existing products; the impact of a weak economy on demand for the Company's products and services; the effectiveness of the Company's sales and marketing activities; disruptions, shortages or pricing changes that affect the Company's purchases of products and materials from third parties, including from sole source suppliers; the Company's ability to manufacture complex biologic products; the effect of government regulation on the Company's business, including government decisions about whether and when to approve the Company's products and decisions regarding labeling, manufacturing and marketing products; changes or trends in veterinary medicine that affect the rate of use of the Company's products and services by veterinarians; the effects of operations outside the U.S., including from currency fluctuations, different regulatory, political and economic conditions, and different market conditions; and the effects of interruptions to the Company's operations due to natural disasters or system failures. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2012 (PDF), in the section captioned "Risk Factors.


Contact:

IDEXX Laboratories
Penny Guyton
Sr. Director and General Manager, IDEXX Digital Imaging
1-207-556-8383
penny-guyton@idexx.com